Unique Sphingolipid Signature Identifies Luminal and Triple-Negative Breast Cancer Subtypes. Kar A, Medatwal N, Rajput K, Mandal S, et al. Int J Cancer 2023 Jan 5. doi: 10.1002/ijc.34423.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kar A, Medatwal N, Rajput K, Mandal S, et al. Unique Sphingolipid Signature Identifies Luminal and Triple-Negative Breast Cancer Subtypes. Int J Cancer 2023 Jan 5. doi: 10.1002/ijc.34423.
PMID: 36602287